Default: Current Opinion in Pharmacology

ISSN: 1471-4892

Journal Home

Journal Guideline

Current Opinion in Pharmacology Q1 Unclaimed

Elsevier BV Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Pharmacology is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 127. It has an SJR impact factor of 1,989 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


- €

Gold OA


Green OA

- €

Non OA


Current Opinion in Pharmacology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Best articles

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer

View more

A new era for gastrointestinal research - novel therapeutic targets for drug development

View more

Acid-sensitive ion channels in gastrointestinal function

View more

Adult growth hormone replacement: current understanding

View more

Anti-infective challenges in the 21st century: from superbugs to viral pandemics

View more


View more

Anti-infectives New technologies

View more

Anti-infectives: New technologies

View more

Anti-inflammatory therapy for heart failure

View more

Applications of microarrays in the pharmaceutical industry

View more

beta-Lactamase-inhibitor combinations in the 21st century: current agents and new developments

View more

Calcium channels in enteric neurons

View more

Cancer Immunomodulation

View more

Cellular screening assays using fluorescence microscopy

View more

CFTR pharmacology and its role in intestinal fluid secretion

View more

Changes and challenges - the world post-Gleevec™ (Glivec®)

View more

Clinical uses and misuses of dehydroepiandrosterone

View more

Conductances responsible for slow wave generation and propagation in interstitial cells of Cajal

View more


View more

Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs

View more

Cyclooxygenase-2 and inflammation in atherosclerosis

View more

Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development

View more

Drug inhibition of angiogenesis

View more

Drug transport via the intestinal peptide transporter PepT1

View more


No comments ... Be the first to comment!